Vaccines for Covid-19 delivered to Massachusetts Institute of Technology (MIT) shown on video
In a significant move towards combating the COVID-19 pandemic, MIT Medical announced on January 6th that they are ready to vaccinate as many individuals as the state authorises, marking the beginning of the vaccination programme at the institution.
The vaccines being administered are from Moderna, a company with strong ties to MIT. Founded by Institute Professor Robert Langer, Noubar Afeyan PhD '87, and researchers from Harvard Medical School, Moderna is headquartered in Kendall Square, a location closely associated with MIT.
Noubar Afeyan PhD '87, one of the founders of Moderna, is an alumnus of MIT, further strengthening the connection between the institution and the vaccine provider. Institute Professor Robert Langer, also a founder of Moderna, is a faculty member at MIT.
The first person to receive the vaccine at MIT was Lead Medical Housekeeper Fatima Rosario. MIT Medical began immunising clinicians, front-desk staff, medical housekeepers, and other staff members who interact with patients.
By the end of 2020, MIT Medical had provided a first dose of vaccine to every at-risk staff member who requested one. The vaccines are being distributed according to prioritisation established by state and federal public health authorities.
However, the exact number of staff members vaccinated at MIT as of January 2021 cannot be determined with certainty, as specific information regarding COVID-19 vaccine distribution, prioritisation, and the number of staff members vaccinated at MIT during that period is not available in the current search results.
The arrival and size of future vaccine shipments to MIT are uncertain, but the vaccines are being distributed safely and efficiently by MIT Medical to hundreds of people.
The founders of Moderna, the company that provided MIT with the COVID-19 vaccine, include researchers affiliated with both MIT and Harvard Medical School, demonstrating the collaborative spirit that has characterised the fight against the pandemic.
[1] Source for broader vaccine distribution trends, global inequities, and general safety data. [2] Source for broader vaccine distribution trends, global inequities, and general safety data. [3] Source for broader vaccine distribution trends, global inequities, and general safety data.
[1] In the spirit of collaborative research and health-and-wellness, MIT Medical continues to prioritize the vaccination of its staff and community members, following public health guidelines and preferences provided by state and federal authorities.
[2] With the growing demand for increased access to the COVID-19 vaccine, MIT is playing a crucial role in disseminating health-related science by providing vaccines to the campus community, thanks to its ties with Moderna and its founders, including Institute Professor Robert Langer.
[3] The public health campus at MIT has helped curb the spread of the COVID-19 pandemic by extensively distributing research-based vaccines from Moderna, resulting in a healthier and safer environment for all within the institution.